Skip to main content

Table 2 Association between HIF1α expression scores and Clinico-pathological data of the studied cases; (N = 71)

From: Prognostic significance of HIF1-α immunohistochemical expression in gliomas and it's relation to IDH1 mutation status

Variables

 

Negative (19)

Score +1 (18)

Score +2 (23)

Score +3 (11)

Total 71

P-value

Gender (N = 71)

Male

9 (26.5%)

8 (23.5%)

10 (29.4%)

7 (20.6%)

34

0.689

Female

10 (27.0%)

10 (27.0%)

13 (35.1%)

4 (10.8%)

37

Side (N = 71)

Right

8 (28.6%)

4 (14.3%)

13 (46.4%)

3 (10.7%)

28

0.041*

Left

6 (18.8%)

9 (28.1%)

9 (28.1%)

8 (25.0%)

32

Midline

5 (45.5%)

5 (45.5%)

1 (9.1%)

0 (0.0%)

11

Relation to tentorium cerebelli (N = 69)**

Supra-tentorial

13 (22.0%)

13 (22.0%)

22 (37.3%)

11 (18.6%)

59

0.037*

Infra-tentorial

6 (60.0%)

3 (30.0%)

1 (10.0%)

0 (0.0%)

10

Recurrence (N = 71)

First time

18 (30.50%)

15 (25.40%)

18 (30.50%)

8 (13.60%)

59

0.383

Recurrent

1 (8.30%)

3 (25.00%)

5 (41.70%)

3 (25.00%)

12

Necrosis (N = 71)

Negative for necrosis

13 (43.3%)

11 (36.7%)

6 (20.0%)

0 (0.0%)

30

< 0.001*

Positive for necrosis

6 (14.6%)

7 (17.1%)

17 (41.5%)

11 (26.8%)

41

IDH1-R132H expression (N = 51)

Negative

0 (0.0%)

3 (15.8%)

10 (52.6%)

6 (31.6%)

19

0.012*

Positive

11 (34.4%)

8 (25.0%)

8 (25.0%)

5 (15.6%)

32

  1. *P-value ≤ 0.05 is considered significant
  2. **Two cases were excluded from total as they were spinal tumors (extracranial)